pyridostigmine bromide has been researched along with physostigmine in 70 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 33 (47.14) | 18.7374 |
1990's | 15 (21.43) | 18.2507 |
2000's | 12 (17.14) | 29.6817 |
2010's | 9 (12.86) | 24.3611 |
2020's | 1 (1.43) | 2.80 |
Authors | Studies |
---|---|
Bellows, DS; Clarke, ID; Diamandis, P; Dirks, PB; Graham, J; Jamieson, LG; Ling, EK; Sacher, AG; Tyers, M; Ward, RJ; Wildenhain, J | 1 |
Fisk, L; Greene, N; Naven, RT; Note, RR; Patel, ML; Pelletier, DJ | 1 |
Brossi, A; Greig, NH; Holloway, HW; Lahiri, DK; Luo, W; Yu, QS | 1 |
Ekins, S; Williams, AJ; Xu, JJ | 1 |
Havard, CW; Lange, MJ | 1 |
Watts, P; Wilkinson, RG | 1 |
Bräunlich, H; Hartwich, R | 1 |
Gattenlöhner, W; Rasenack, U | 1 |
Landauer, W | 1 |
Galli, A; Mori, F | 1 |
Fischer, JP; Kewitz, H; Thomsen, T; Zendeh, B | 1 |
Anderson, D; Carchman, RA; Carter, WH; Gennings, C; Harris, LW; Lennox, WJ; Solana, RP | 1 |
Davis, LH; Kauffman, FC; Whittaker, M | 1 |
Dusticier, N; Ebihara, Y; Gauthier, GM; Nieoullon, A; Vercher, JL | 1 |
Husain, K; Marjit, DN; Vijayaraghavan, R | 1 |
Gross, CL; Kagey-Sobotka, A; Kilduff, JE; Meier, HL; Papirmeister, B | 1 |
Finger, AV; McMaster, SB | 1 |
Bass, KN; Das Gupta, S; Warnick, JE | 1 |
Arndt, H; Sprengard, M | 1 |
Riker, WF | 1 |
Kewitz, H; Pleul, O; Thomsen, T | 1 |
Albuquerque, EX; Aracava, Y; Brossi, A; Cintra, WM; Deshpande, SS; Schönenberger, B | 1 |
Beasley, VR; Carmichael, WW; Cook, WO; Dahlem, AM; Dellinger, JA; Harlin, KS | 1 |
Birnbaum, SG; Dellinger, JA; Jansen, HT; Zaber, DJ | 1 |
Brecht, KM; Lenz, DE; Maxwell, DM; O'Neill, BL | 1 |
Annau, Z; Mansour, NA; Shamoo, AE; Valdes, JJ | 1 |
Domino, EF | 1 |
King, JM; Romano, JA | 1 |
Albuquerque, EX; Deshpande, SS; Kauffman, FC; Rickett, DL; Viana, GB | 1 |
Bonds, AB; DeBruyn, EJ; Gajewski, YA | 1 |
Albuquerque, EX; Eldefrawi, AT; Eldefrawi, ME; Sherby, SM | 1 |
Anderson, DR; Harris, LW; Lennox, WJ; Talbot, BG | 1 |
Inns, RH; Leadbeater, L; Rylands, JM | 1 |
Schneider, R | 1 |
Cowan, A; Wray, SR | 1 |
Lagerquist, B; Morgan, GM; Stone, CA; Torchiana, ML; Wenger, HC | 1 |
Williams, D | 1 |
Fuhrmann, M; Gassner, B; Gössinger, H; Hruby, K; Shroff, D | 1 |
Akaike, A; Albuquerque, EX; Rickett, DL; Shaw, KP | 1 |
Harris, L; Stitcher, D | 1 |
Loh, L; Schott, GD | 1 |
Anderson, DR; Harris, LW; Lennox, WJ; Swanson, DR; Talbot, BG | 1 |
Dawson, RM | 1 |
Blick, DW; Brown, GC; Murphy, MR; Weathersby, FR | 1 |
Arvat, E; Bellone, J; Boffano, G; Camanni, F; Ghigo, E; Maccario, M; Mazza, E; Müller, EE; Procopio, M; Valetto, M | 1 |
Das Gupta, S; Husain, K; Kumar, P; Singh, R; Vijayaraghavan, R | 1 |
Blick, DW; Brown, GC; Miller, SA; Murphy, MR | 1 |
Friedman, A; Hendler, I; Kaufer, D; Shemer, J; Soreq, H; Tur-Kaspa, I | 1 |
Backman, SB; Collier, B; Polosa, C; Stein, RD | 1 |
Ariel, N; Barak, D; Bino, T; Ordentlich, A; Shafferman, A; Velan, B | 1 |
Hänninen, O; Kaliste-Korhonen, E; Raushel, FM; Tuovinen, K | 1 |
Alkalai, D; Cohen, G; Grauer, E; Kapon, J; Raveh, L | 1 |
Fitch, TE; Haley, RW; Petty, F; Sinton, CM | 1 |
Ben Nathan, D; Danenberg, HD; Grauer, E; Kapon, J; Kobiler, D; Lustig, S | 1 |
Aubriot, S; Baubichon, D; Carpentier, P; Dorandeu, F; Foquin, A; Lallement, G | 1 |
Baubichon, D; Carpentier, P; Dorandeu, F; Foquin, A; Lallement, G | 1 |
Barahona, V; Sánchez-Fortún, S | 1 |
Hall, T; Passingham, S; Wetherell, J | 1 |
BOUDIN, G; GOULON, M; HAMBURGER, J; LAPRESLE, J; LHERMITTE, F; PEQUIGNOT, H | 1 |
Eckert, S; Eyer, P; Mückter, H; Worek, F | 1 |
Barahona, MV; Sánchez-Fortún, S | 1 |
Bumm, R; Eckert, S; Eyer, P; Herkert, NM; Thiermann, H; Weber, G; Worek, F | 1 |
Barak, D; Greig, NH; Ordentlich, A; Shafferman, A; Stein, D; Yu, QS | 1 |
Grubbs, RD; Lucot, JB; Mauck, B; Paton, S | 1 |
Hasan, MY; Kuča, K; Lorke, DE; Nurulain, SM; Petroianu, GA; Shafiullah, M | 2 |
Herkert, NM; Thiermann, H; Worek, F | 1 |
Hasan, MY; Kuča, K; Lorke, DE; Nurulain, SM; Petroianu, GA | 2 |
Calas, AG; Krejci, E; Nachon, F; Nervo, A | 1 |
3 review(s) available for pyridostigmine bromide and physostigmine
Article | Year |
---|---|
[Myasthenia gravis].
Topics: Autoimmune Diseases; Cholinesterase Inhibitors; Humans; Myasthenia Gravis; Neostigmine; Physostigmine; Pyridostigmine Bromide; Thymectomy; Thymoma; Thymus Neoplasms | 1977 |
[Tricyclic antidepressive agents: clinical aspects and therapy of poisoning].
Topics: Antidepressive Agents, Tricyclic; Arrhythmias, Cardiac; Brain Diseases; Brain Edema; Diazepam; Gastric Lavage; Humans; Hypotension; Myocardial Infarction; Pacemaker, Artificial; Physostigmine; Pyridostigmine Bromide; Respiration, Artificial; Salicylates | 1976 |
Structure-activity relationship of reversible cholinesterase inhibitors: activation, channel blockade and stereospecificity of the nicotinic acetylcholine receptor-ion channel complex.
Topics: Animals; Binding Sites; Chemical Phenomena; Chemistry; Cholinesterase Inhibitors; Edrophonium; Muscle Contraction; Neostigmine; Organophosphate Poisoning; Physostigmine; Pyridostigmine Bromide; Rana pipiens; Receptors, Nicotinic; Sciatic Nerve; Structure-Activity Relationship | 1988 |
67 other study(ies) available for pyridostigmine bromide and physostigmine
Article | Year |
---|---|
Chemical genetics reveals a complex functional ground state of neural stem cells.
Topics: Animals; Cell Survival; Cells, Cultured; Mice; Molecular Structure; Neoplasms; Neurons; Pharmaceutical Preparations; Sensitivity and Specificity; Stem Cells | 2007 |
Developing structure-activity relationships for the prediction of hepatotoxicity.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Humans; Structure-Activity Relationship; Tetracyclines; Thiophenes | 2010 |
Long-acting anticholinesterases for myasthenia gravis: synthesis and activities of quaternary phenylcarbamates of neostigmine, pyridostigmine and physostigmine.
Topics: Acetylcholinesterase; Animals; Butyrylcholinesterase; Cholinesterase Inhibitors; Humans; Mice; Myasthenia Gravis; Neostigmine; Phenylcarbamates; Physostigmine; Pyridostigmine Bromide | 2010 |
A predictive ligand-based Bayesian model for human drug-induced liver injury.
Topics: Bayes Theorem; Chemical and Drug Induced Liver Injury; Humans; Ligands | 2010 |
The interaction of carbamates with acetylcholinesterase.
Topics: Acetylcholinesterase; Animals; Benzofurans; Carbachol; Carbamates; Cattle; Erythrocytes; Insecticides; Kinetics; Physostigmine; Pyridostigmine Bromide | 1977 |
[The use of direct and indirect parasympathomimetics in poisonings with tricyclic antidepressive agents].
Topics: Amitriptyline; Animals; Antidepressive Agents, Tricyclic; Arecoline; Cholinesterase Inhibitors; Coma; Dibenzocycloheptenes; Imipramine; Paraoxon; Physostigmine; Pyridostigmine Bromide; Rats | 1978 |
Cholinomimetic teratogens: studies with chicken embryos.
Topics: Acetylcholine; Animals; Carbachol; Chick Embryo; Choline; Cholinesterase Inhibitors; Decamethonium Compounds; Drug Synergism; Gallamine Triethiodide; Musculoskeletal System; Neostigmine; Nicotine; Parasympathomimetics; Physostigmine; Pyridostigmine Bromide; Quaternary Ammonium Compounds; Succinylcholine; Teratogens | 1975 |
Effectiveness of 1,2,3,4-tetrahydro-9-aminoacridine (THA) as a pretreatment drug for protection of mice from acute diisopropylfluorophosphate (DFP) intoxication.
Topics: Animals; Brain; Cholinesterase Inhibitors; Diaphragm; Dose-Response Relationship, Drug; Isoflurophate; Male; Mice; Physostigmine; Poisoning; Pyridostigmine Bromide; Tacrine; Time Factors | 1991 |
In vitro effects of various cholinesterase inhibitors on acetyl- and butyrylcholinesterase of healthy volunteers.
Topics: Acetylcholinesterase; Butyrylcholinesterase; Cholinesterase Inhibitors; Erythrocytes; Humans; Physostigmine; Pyridostigmine Bromide; Tacrine; Tetraisopropylpyrophosphamide | 1991 |
Evaluation of the efficacy of two carbamates, physostigmine and pyridostigmine, when used in conjunction for protection against organophosphate exposure.
Topics: Acetylcholinesterase; Animals; Cholinesterase Inhibitors; Female; Guinea Pigs; Lethal Dose 50; Male; Models, Biological; Organophosphorus Compounds; Physostigmine; Pyridostigmine Bromide; Regression Analysis; Soman | 1990 |
Activation of glycogen phosphorylase in rat pheochromocytoma PC12 cells and isolated hepatocytes by organophosphates.
Topics: Adenine Nucleotides; Animals; Calcium; Cells, Cultured; Cytosol; Dose-Response Relationship, Drug; Drug Interactions; Enzyme Activation; Hydrogen-Ion Concentration; Liver; Male; Organophosphorus Compounds; Pheochromocytoma; Phosphorylase a; Phosphorylases; Physostigmine; Pyridostigmine Bromide; Rats; Tumor Cells, Cultured; Verapamil | 1990 |
Pyridostigmine-induced inhibition of blood acetylcholinesterase (AChE) and resulting effects on manual ocular tracking performance in the trained baboon.
Topics: Acetylcholine; Acetylcholinesterase; Animals; Attention; Dose-Response Relationship, Drug; Eye Movements; Female; Injections, Intramuscular; Ketamine; Kinesthesis; Male; Papio; Physostigmine; Psychomotor Performance; Pursuit, Smooth; Pyridostigmine Bromide | 1990 |
The effect of pyridostigmine and physostigmine on acute toxicity of diisopropyl fluorophosphate in rats.
Topics: Acetylcholinesterase; Animals; Blood Glucose; Glycogen; Isoflurophate; Male; Physostigmine; Pyridostigmine Bromide; Rats | 1990 |
Histamine release by esterase inhibitors. The regulation of histamine release from human leukocytes of allergic and non-allergic individuals by the serine esterase inhibitors diisopropyl fluorophosphate and pinacolyl methylphosphorofluoridate.
Topics: Enzyme Inhibitors; Esterases; Histamine Release; Humans; Hypersensitivity; Isoflurophate; Kinetics; Organophosphorus Compounds; Physostigmine; Pyridostigmine Bromide; Soman; Temperature | 1985 |
Effects of exercise on behavioral sensitivity to carbamate cholinesterase inhibitors.
Topics: Animals; Behavior, Animal; Conditioning, Operant; Dose-Response Relationship, Drug; Male; Physical Conditioning, Animal; Physical Exertion; Physostigmine; Pyridostigmine Bromide; Random Allocation; Rats; Rats, Inbred Strains; Reinforcement Schedule | 1989 |
Interaction of reversible and irreversible cholinesterase inhibitors on the monosynaptic reflex in neonatal rats.
Topics: Animals; Atropine; Cholinesterase Inhibitors; Dose-Response Relationship, Drug; Female; In Vitro Techniques; Male; Physostigmine; Pregnancy; Pyridostigmine Bromide; Rats; Rats, Inbred Strains; Reflex, Monosynaptic; Sarin; Spinal Cord | 1989 |
Effects of carbamates upon various behavioural parameters in mice.
Topics: Animals; Behavior, Animal; Carbamates; Dose-Response Relationship, Drug; Double-Blind Method; Male; Mice; Motor Activity; Physostigmine; Psychomotor Performance; Pyridostigmine Bromide; Respiration | 1989 |
Memory impairment in myasthenia gravis.
Topics: Cognition Disorders; Humans; Memory Disorders; Myasthenia Gravis; Physostigmine; Pyridostigmine Bromide | 1989 |
Estimation of cholinesterase activity (EC 3.1.1.7; 3.1.1.8) in undiluted plasma and erythrocytes as a tool for measuring in vivo effects of reversible inhibitors.
Topics: Acetylcholinesterase; Butyrylcholinesterase; Carbon Radioisotopes; Cholinesterase Inhibitors; Cholinesterases; Erythrocytes; Female; Humans; Kinetics; Male; Physostigmine; Pyridostigmine Bromide; Radioisotope Dilution Technique; Reference Values; Sex Factors; Tacrine | 1988 |
Comparison of effects of anatoxin-a(s) and paraoxon, physostigmine and pyridostigmine on mouse brain cholinesterase activity.
Topics: Animals; Bacterial Toxins; Brain; Cholinesterase Inhibitors; Cholinesterases; Cyanobacteria Toxins; Lethal Dose 50; Male; Marine Toxins; Mice; Mice, Inbred BALB C; Microcystins; Paraoxon; Physostigmine; Pyridostigmine Bromide; Rats; Tropanes | 1988 |
Vagal tone monitoring: a potential indicator of anti-cholinesterase exposure in Macaca mulatta.
Topics: Acetylcholinesterase; Animals; Atropine; Cholinesterase Inhibitors; Erythrocytes; Macaca mulatta; Monitoring, Physiologic; Physostigmine; Pyridostigmine Bromide; Vagus Nerve | 1988 |
Effect of carboxylesterase inhibition on carbamate protection against soman toxicity.
Topics: Acetylcholinesterase; Animals; Carboxylesterase; Carboxylic Ester Hydrolases; Guinea Pigs; Lethal Dose 50; Male; Organophosphorus Compounds; Physostigmine; Pyridostigmine Bromide; Rabbits; Rats; Rats, Inbred Strains; Soman | 1988 |
Biochemical interactions of carbamates and ecothiophate with the activated conformation of nicotinic acetylcholine receptor.
Topics: Biotransformation; Bungarotoxins; Carbamates; Echothiophate Iodide; Neostigmine; Phencyclidine; Physostigmine; Pyridostigmine Bromide; Receptors, Nicotinic | 1987 |
Comparative seizure inducing properties of various cholinesterase inhibitors: antagonism by diazepam and midazolam.
Topics: Animals; Atropine; Behavior, Animal; Cholinesterase Inhibitors; Diazepam; Isoflurophate; Male; Midazolam; Neostigmine; Paraoxon; Physostigmine; Pyridostigmine Bromide; Rats; Rats, Inbred Strains; Seizures | 1987 |
Conditioned taste aversion and cholinergic drugs: pharmacological antagonism.
Topics: Animals; Atropine; Avoidance Learning; Benactyzine; Conditioning, Classical; Male; Parasympathomimetics; Physostigmine; Pyridostigmine Bromide; Rats; Saccharin; Taste | 1987 |
Effectiveness of physostigmine as a pretreatment drug for protection of rats from organophosphate poisoning.
Topics: Acetylcholinesterase; Action Potentials; Animals; Atropine; Body Weight; Brain; Brain Chemistry; Cholinesterases; Female; gamma-Aminobutyric Acid; Muscle Contraction; Muscles; Neostigmine; Organophosphate Poisoning; Physostigmine; Pyridostigmine Bromide; Rats; Rats, Inbred Strains; Sarin | 1986 |
Anticholinesterase agents affect contrast gain of the cat cortical visual evoked potential.
Topics: Acetylcholine; Animals; Atropine; Cats; Cholinesterase Inhibitors; Evoked Potentials, Visual; Isoflurophate; Physostigmine; Pyridostigmine Bromide; Soman; Visual Cortex; Visual Perception | 1986 |
Comparison of the actions of carbamate anticholinesterases on the nicotinic acetylcholine receptor.
Topics: Acetylcholine; Amphibian Venoms; Animals; Binding, Competitive; Bungarotoxins; Carbachol; Electric Organ; Kinetics; Neostigmine; Physostigmine; Pyridostigmine Bromide; Receptors, Cholinergic; Torpedo | 1985 |
Relationship between reversible acetylcholinesterase inhibition and efficacy against soman lethality.
Topics: Acetylcholinesterase; Animals; Atropine; Cholinesterase Inhibitors; Dose-Response Relationship, Drug; Drug Therapy, Combination; Female; Guinea Pigs; Male; Mecamylamine; Organophosphorus Compounds; Physostigmine; Pralidoxime Compounds; Pyridostigmine Bromide; Rats; Soman | 1985 |
Treatment of poisoning by soman.
Topics: Animals; Antidotes; Atropine; Carbamates; Diazepam; Guinea Pigs; Male; Motor Activity; Organophosphate Poisoning; Parasympatholytics; Phenylpropionates; Physostigmine; Pyridostigmine Bromide; Sarin; Soman; Time Factors | 1985 |
A test for the assessment of the duration of the action of neostigmine and of the relative potencies of various anticholinesterases using the pupil of the mouse.
Topics: Animals; Atropine; Cholinesterase Inhibitors; Edrophonium; Female; Male; Methods; Mice; Miotics; Neostigmine; Physostigmine; Pupil; Pyridostigmine Bromide; Time Factors | 1970 |
Correlation between animal and clinical findings with a psychotomimetic anticholinesterase.
Topics: Animals; Avoidance Learning; Cholinesterase Inhibitors; Cyclohexanes; Female; Hallucinogens; Lysergic Acid Diethylamide; Physostigmine; Pyridostigmine Bromide; Pyrrolidines; Rats; Time Factors | 1973 |
Pharmacological antagonism of the toxic manifestations of amitriptyline and protriptyline in dogs.
Topics: Amitriptyline; Animals; Antidepressive Agents; Dibenzocycloheptenes; Dogs; Drug Antagonism; Electrocardiography; Heart Rate; Mecamylamine; Methylamines; Physostigmine; Propranolol; Propylamines; Pyridostigmine Bromide | 1972 |
The management of myasthenia.
Topics: Adult; Ambenonium Chloride; Carcinoma, Bronchogenic; Ephedrine; Female; Follow-Up Studies; Humans; Hyperthyroidism; Lung Neoplasms; Male; Middle Aged; Muscular Diseases; Myasthenia Gravis; Myositis; Neostigmine; Oculomotor Muscles; Physostigmine; Pyridostigmine Bromide; Thymectomy; Thymoma; Thymus Neoplasms | 1967 |
[Clinical aspects and therapy of acute poisoning by the drug combination melitracen-flupenthixol (Deanxit)].
Topics: Adolescent; Adult; Anthracenes; Basal Ganglia Diseases; Biperiden; Cardiac Complexes, Premature; Child, Preschool; Coma; Drug Combinations; Female; Flupenthixol; Gastric Lavage; Humans; Male; Middle Aged; Physostigmine; Pyridostigmine Bromide; Tachycardia; Thioxanthenes | 1983 |
The interaction of anticholinesterase agents with the acetylcholine receptor-ionic channel complex.
Topics: Action Potentials; Animals; Anura; Cholinesterase Inhibitors; In Vitro Techniques; Ion Channels; Motor Endplate; Muscle Contraction; Physostigmine; Pyridostigmine Bromide; Rats; Receptors, Cholinergic; Receptors, Nicotinic | 1984 |
Protection against diisopropylfluorophosphate intoxication by pyridostigmine and physostigmine in combination with atropine and mecamylamine.
Topics: Acetylcholine; Acetylcholinesterase; Animals; Antidotes; Atropine; Brain Chemistry; Drug Combinations; Isoflurophate; Male; Mecamylamine; Physostigmine; Pyridostigmine Bromide; Rats | 1984 |
Anticholinesterase drugs in the treatment of chronic pain.
Topics: Arm; Cholinesterase Inhibitors; Chronic Disease; Humans; Leg; Male; Middle Aged; Neostigmine; Pain; Physostigmine; Propantheline; Pyridostigmine Bromide; Shoulder; Syndrome | 1984 |
Toxicity of anticholinesterases: interactions of pyridostigmine and physostigmine with soman.
Topics: Acetylcholinesterase; Animals; Drug Interactions; Lethal Dose 50; Male; Motor Activity; Organophosphorus Compounds; Physostigmine; Pyridostigmine Bromide; Rats; Rats, Inbred Strains; Soman | 1984 |
Oxime effects on the rate constants of carbamylation and decarbamylation of acetylcholinesterase for pyridostigmine, physostigmine and insecticidal carbamates.
Topics: Acetylcholinesterase; Animals; Cattle; Erythrocytes; In Vitro Techniques; Insecticides; Kinetics; Oximes; Physostigmine; Pyridostigmine Bromide; Structure-Activity Relationship | 1995 |
Behavioral toxicity of anticholinesterases in primates: effects of daily repeated soman exposure.
Topics: Animals; Behavior, Animal; Cholinesterase Inhibitors; Cholinesterases; Macaca mulatta; Male; Physostigmine; Postural Balance; Psychomotor Performance; Pyridostigmine Bromide; Soman | 1994 |
Effects of direct and indirect acetylcholine receptor agonists on growth hormone secretion in humans.
Topics: Adult; Bethanechol Compounds; Cholinergic Antagonists; Cholinesterase Inhibitors; Female; Flushing; Growth Hormone; Growth Hormone-Releasing Hormone; Humans; Injections, Intravenous; Male; Neostigmine; Physostigmine; Pyridostigmine Bromide; Receptors, Cholinergic | 1994 |
Influence of pretreatment of carbamates on dynamic pulmonary mechanics in rats exposed to sarin aerosols.
Topics: Aerosols; Animals; Carbamates; Male; Physostigmine; Pyridostigmine Bromide; Rats; Rats, Wistar; Respiratory Mechanics; Sarin | 1993 |
Behavioral toxicity of anticholinesterases in primates: chronic physostigmine and soman interactions.
Topics: Animals; Behavior, Animal; Cholinesterase Inhibitors; Cholinesterases; Drug Interactions; Injections, Subcutaneous; Macaca mulatta; Male; Physostigmine; Psychomotor Performance; Pyridostigmine Bromide; Soman | 1993 |
Pyridostigmine brain penetration under stress enhances neuronal excitability and induces early immediate transcriptional response.
Topics: Acetylthiocholine; Animals; Blood-Brain Barrier; Brain; Cell Membrane Permeability; Cholinesterase Inhibitors; Evoked Potentials; Gene Expression Regulation; Genes, Immediate-Early; Hippocampus; Mice; Molecular Sequence Data; Persian Gulf Syndrome; Physostigmine; Proto-Oncogene Proteins c-fos; Pyridostigmine Bromide; RNA, Messenger; Stress, Physiological; Transcription, Genetic | 1996 |
Bradycardia produced by pyridostigmine and physostigmine.
Topics: Animals; Bradycardia; Cats; Cholinesterase Inhibitors; Cholinesterases; Dose-Response Relationship, Drug; Electric Stimulation; Erythrocytes; Heart Rate; Muscarinic Antagonists; Nicotinic Antagonists; Physostigmine; Pyridostigmine Bromide; Vagotomy | 1997 |
The 'aromatic patch' of three proximal residues in the human acetylcholinesterase active centre allows for versatile interaction modes with inhibitors.
Topics: Acetylcholinesterase; Alkaloids; Binding Sites; Cholinesterase Inhibitors; Crystallography, X-Ray; Humans; Hydrogen Bonding; Kinetics; Ligands; Models, Chemical; Models, Molecular; Physostigmine; Protein Conformation; Pyridostigmine Bromide; Sesquiterpenes; Structure-Activity Relationship; Tacrine | 1998 |
Success of pyridostigmine, physostigmine, eptastigmine and phosphotriesterase treatments in acute sarin intoxication.
Topics: Animals; Antidotes; Aryldialkylphosphatase; Esterases; Lethal Dose 50; Male; Mice; Physostigmine; Pyridostigmine Bromide; Sarin | 1999 |
Stress does not enable pyridostigmine to inhibit brain cholinesterase after parenteral administration.
Topics: Animals; Brain; Cholinesterase Inhibitors; Cholinesterases; Cold Temperature; Female; Male; Mice; Physostigmine; Pyridostigmine Bromide; Stress, Physiological; Swimming | 2000 |
Stressful manipulations that elevate corticosterone reduce blood-brain barrier permeability to pyridostigmine in the Rat.
Topics: Acetylcholinesterase; Anesthetics, Inhalation; Animals; Anti-Inflammatory Agents; Blood-Brain Barrier; Brain; Central Nervous System; Cholinesterase Inhibitors; Corticosterone; Halothane; Male; Mice; Permeability; Physostigmine; Pyridostigmine Bromide; Rats; Rats, Long-Evans; Rats, Wistar; Stress, Physiological | 2000 |
Viral neuroinvasion as a marker for BBB integrity following exposure to cholinesterase inhibitors.
Topics: Alphavirus Infections; Animals; Blood-Brain Barrier; Brain; Central Nervous System Diseases; Cholinesterase Inhibitors; Dose-Response Relationship, Drug; Female; Lethal Dose 50; Mice; Mice, Inbred ICR; Permeability; Physostigmine; Pyridostigmine Bromide; Sindbis Virus; Soman; Viremia | 2001 |
Subchronic administration of various pretreatments of nerve agent poisoning. I. Protection of blood and central cholinesterases, innocuousness towards blood-brain barrier permeability.
Topics: Alkaloids; Animals; Blood-Brain Barrier; Brain; Cholinesterase Inhibitors; Cholinesterases; Erythrocytes; Evans Blue; Guinea Pigs; Male; Microscopy, Fluorescence; Neuroprotective Agents; Physostigmine; Pyridostigmine Bromide; Serum Albumin; Sesquiterpenes | 2001 |
Subchronic administration of various pretreatments of nerve agent poisoning. II. Compared efficacy against soman toxicity.
Topics: Alkaloids; Animals; Cholinesterase Inhibitors; Electroencephalography; Guinea Pigs; Male; Neuroprotective Agents; Physostigmine; Pyridostigmine Bromide; Scopolamine; Seizures; Sesquiterpenes; Soman; Time Factors | 2001 |
The use of carbamates, atropine, and 2-pyridine aldoxime methoiodide in the protection of Artemia salina against poisoning by carbophenothion.
Topics: Animals; Artemia; Atropine; Cholinesterase Inhibitors; Cholinesterase Reactivators; Dose-Response Relationship, Drug; Drug Interactions; Insecticides; Lethal Dose 50; Muscarinic Antagonists; Organothiophosphorus Compounds; Physostigmine; Pralidoxime Compounds; Pyridostigmine Bromide; Water Pollutants, Chemical | 2001 |
Physostigmine and hyoscine improves protection against the lethal and incapacitating effects of nerve agent poisoning in the guinea-pig.
Topics: Animals; Antidotes; Body Temperature; Chemical Warfare Agents; Cholinesterase Inhibitors; Cholinesterases; Drug Implants; Guinea Pigs; Male; Muscarinic Antagonists; Organothiophosphorus Compounds; Physostigmine; Pyridostigmine Bromide; Scopolamine; Weight Gain | 2002 |
[HOW TO TREAT MYASTHENIA].
Topics: Ambenonium Chloride; Ephedrine; Humans; Muscle Weakness; Myasthenia Gravis; Neostigmine; Physostigmine; Prognosis; Pyridostigmine Bromide; Respiratory Insufficiency; Spironolactone; Surgical Procedures, Operative; Thymus Neoplasms | 1964 |
Kinetic analysis of the protection afforded by reversible inhibitors against irreversible inhibition of acetylcholinesterase by highly toxic organophosphorus compounds.
Topics: Acetylcholinesterase; Algorithms; Alkaloids; Carbamates; Cholinesterase Inhibitors; Cholinesterase Reactivators; Dose-Response Relationship, Drug; Erythrocytes; Humans; Kinetics; Organophosphorus Compounds; Paraoxon; Physostigmine; Pyridostigmine Bromide; Sesquiterpenes; Time Factors | 2006 |
Toxicity and characterization of cholinesterase-inhibition induced by diisopropyl fluorophosphate in Artemia salina larvae.
Topics: Animals; Artemia; Atropine; Cholinesterase Inhibitors; Cholinesterase Reactivators; Drug Therapy, Combination; Isoflurophate; Larva; Longevity; Muscarinic Antagonists; Physostigmine; Pralidoxime Compounds; Pyridostigmine Bromide; Toxicity Tests, Acute; Water Pollutants, Chemical | 2009 |
Identical kinetics of human erythrocyte and muscle acetylcholinesterase with respect to carbamate pre-treatment, residual activity upon soman challenge and spontaneous reactivation after withdrawal of the inhibitors.
Topics: Acetylcholinesterase; Carbamates; Cholinesterase Inhibitors; Dose-Response Relationship, Drug; Enzyme Activation; Erythrocytes; Humans; Kinetics; Muscle, Skeletal; Physostigmine; Pyridostigmine Bromide; Soman | 2008 |
Accommodation of physostigmine and its analogues by acetylcholinesterase is dominated by hydrophobic interactions.
Topics: Acetylcholinesterase; Binding Sites; Catalysis; Cholinesterase Inhibitors; Humans; Hydrophobic and Hydrophilic Interactions; Kinetics; Models, Molecular; Molecular Structure; Mutation; Phenylcarbamates; Physostigmine; Protein Binding; Pyridostigmine Bromide; Rivastigmine; Structure-Activity Relationship | 2009 |
Cholinesterase inhibitors and stress: effects on brain muscarinic receptor density in mice.
Topics: Animals; Brain; Cholinesterase Inhibitors; Cholinesterases; Disease Models, Animal; Dose-Response Relationship, Drug; Male; Mice; Mice, Inbred C57BL; Physostigmine; Protein Binding; Pyridostigmine Bromide; Receptors, Muscarinic; Stress, Psychological | 2010 |
Pretreatment for acute exposure to diisopropylfluorophosphate: in vivo efficacy of various acetylcholinesterase inhibitors.
Topics: Amiloride; Animals; Cholinesterase Inhibitors; Dose-Response Relationship, Drug; Erythrocytes; Female; Humans; Inhibitory Concentration 50; Isoflurophate; Male; Methylene Blue; Metoclopramide; Oximes; Physostigmine; Proportional Hazards Models; Pyridinium Compounds; Pyridostigmine Bromide; Ranitidine; Rats; Tacrine; Tiapride Hydrochloride | 2011 |
In vitro kinetic interactions of pyridostigmine, physostigmine and soman with erythrocyte and muscle acetylcholinesterase from different species.
Topics: Acetylcholinesterase; Animals; Carbamates; Cholinesterase Inhibitors; Dose-Response Relationship, Drug; Drug Evaluation, Preclinical; Drug Interactions; Erythrocytes; Female; Guinea Pigs; Humans; In Vitro Techniques; Kinetics; Macaca mulatta; Male; Muscle, Skeletal; Physostigmine; Pyridostigmine Bromide; Soman; Species Specificity; Swine | 2011 |
Usefulness of administration of non-organophosphate cholinesterase inhibitors before acute exposure to organophosphates: assessment using paraoxon.
Topics: Animals; Cholinesterase Inhibitors; Dose-Response Relationship, Drug; Lethal Dose 50; Male; Organophosphate Poisoning; Oximes; Paraoxon; Physostigmine; Pyridostigmine Bromide; Ranitidine; Rats; Rats, Wistar; Tacrine; Tiapride Hydrochloride | 2013 |
Reversible cholinesterase inhibitors as pre-treatment for exposure to organophosphates: assessment using azinphos-methyl.
Topics: Animals; Azinphosmethyl; Cholinesterase Inhibitors; Dose-Response Relationship, Drug; Male; Oximes; Physostigmine; Proportional Hazards Models; Pyridinium Compounds; Pyridostigmine Bromide; Ranitidine; Rats; Rats, Wistar; Tacrine | 2015 |
Respiratory failure triggered by cholinesterase inhibitors may involve activation of a reflex sensory pathway by acetylcholine spillover.
Topics: Acetylcholine; Acetylcholinesterase; Animals; Cholinesterase Inhibitors; Collagen; Female; Irritants; Male; Mice; Mice, Knockout; Muscle Proteins; Neuromuscular Junction; Physostigmine; Pyridostigmine Bromide; Reflex; Respiration; Respiratory Insufficiency; Sensory Receptor Cells; Signal Transduction | 2019 |
Combined Pre- and Posttreatment of Paraoxon Exposure.
Topics: Animals; Cholinesterase Inhibitors; Cholinesterase Reactivators; Male; Organophosphates; Oximes; Paraoxon; Physostigmine; Post-Exposure Prophylaxis; Pre-Exposure Prophylaxis; Proportional Hazards Models; Pyridostigmine Bromide; Ranitidine; Rats; Rats, Wistar; Survival Analysis; Tacrine | 2020 |